Are you Dr. Redman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 54 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Summary
- Dr. Bruce Redman, DO is an oncologist in Ann Arbor, Michigan. He is currently licensed to practice medicine in Michigan and Illinois. He is affiliated with University of Michigan Medical Center and is a Professor at University of Michigan Medical School.
Education & Training
Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 1981
Certifications & Licensure
MI State License 1984 - 2020
IL State License 1982 - 1984
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 6 citationsThe impact of BRAF mutation status on clinical outcomes with anti-PD-1 monotherapy versus combination ipilimumab/nivolumab in treatment-naïve advanced stage melanoma.Vincent T. Ma, Stephanie Daignault-Newton, Jessica Waninger, Sara Journey, Zoey Chopra
Pigment Cell & Melanoma Research. 2021-05-01 - 1 citationsImprovement Initiative to Develop and Implement a Tool for Detecting Drug-Drug Interactions During Oncology Clinical Trial Enrollment Eligibility Screening.Lauren A Marcath, Taylor D. Coe, Faisal Shakeel, Edward Reynolds, Mike Bayuk
Journal of Patient Safety. 2021-01-01 - 197 citationsFeatured Updates to the NCCN GuidelinesRobert J. Motzer, Eric Jonasch, M. Dror Michaelson, Lakshminarayanan Nandagopal, John L. Gore
Journal of the National Comprehensive Cancer Network. 2019-11-01
Grant Support
- Adoptive Therapy Of Renal Cell Carcinoma With Vaccine-Primed LymphocyteNational Center For Research Resources2007
- Tumor-Pulsed Dendritic Cell Vaccine W/ Or W/O IL-2 In PTS W/Metastatic MelanomaNational Center For Research Resources2004–2006
- T Cell Therapy Of Human Renal Cell CancerNational Cancer Institute2001–2002
- Core--Clinical Trials OfficeNational Cancer Institute2001–2002
- Phase 1B Study Of CNI 1493 &Il 2 In Renal Cell Carcinoma &MelanomaNational Center For Research Resources1999–2002
- Autologous Tumor Pulsed Fibrocytes As Tumor Vaccine In Patients W/ CancerNational Center For Research Resources1999–2002
Professional Memberships
- Member
- Member
